← All indications
Neuroectodermal Tumors, Primitive, Peripheral
A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.
Subtype terms (1)
More specific conditions that are subtypes of Neuroectodermal Tumors, Primitive, Peripheral in the MeSH hierarchy.
- Neuroblastoma
328 drugs (166 approved, 162 experimental)
Drugs by status
Organizations
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (37)
- Celgene
- Bristol-Myers Squibb
- Amgen
- Imclone
- Merck
- Eli Lilly
- NantCell, Inc.
- Sarcoma Oncology Research Center, LLC
- Tyme, Inc
- PharmaMar
- National Institutes of Health (NIH)
- Centre Leon Berard
- Cornell University
- Harvard University
- University of Washington
- Grupo Espanol de Investigacion en Sarcomas
- Sarcoma Alliance for Research through Collaboration
- Stanford University
- Universidad Complutense de Madrid
- Thomas Jefferson University
- University of Florida
- University of Michigan
- University of Milan
- University of Seville
- University of Tennessee
- University of Bologna
- Wake Forest University
- University of Valencia
- Istituto Clinico Humanitas - Rozzano (MI), Italy
- City of Hope National Medical Center
- +7 more
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (4)